Entero Therapeutics Risk Adjusted Performance
| ENTODelisted Delisted Stock | | | 2.85 -0.15 -5.00% |
Risk Adjusted Performance for Entero Therapeutics is tracked here with the current value, historical readings, and cross-peer analysis. To screen for instruments by Risk Adjusted Performance thresholds and other criteria, see
Equity Screeners. Context for Entero Therapeutics is enhanced by combining
Entero Therapeutics Volatility with
Entero Therapeutics Price History.
Current Risk Adjusted Performance Value
The current Risk Adjusted Performance of 0 places Entero Therapeutics at slightly negative risk-adjusted return. Entero Therapeutics's return has marginally failed to compensate for the volatility experienced.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | 0 | |
Risk Adjusted Performance Peers Comparison
Risk Adjusted Performance Relative To Other Indicators
The chart below plots Risk Adjusted Performance against Maximum Drawdown for Entero Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Risk Adjusted Performance while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Methodology, Assumptions & Data Sources
Entero Therapeutics' Risk Adjusted Performance currently stands at 0. The Risk Adjusted Performance for Entero Therapeutics is produced by transforming raw price history into a standardized measure according to the indicator's defined methodology. Inputs are drawn from end-of-day closing prices reported by supported exchanges, adjusted for splits and dividends where applicable. The calculation assumes continuous price data across the selected period. All readings are presented as reference data.